KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Biogen (BIIB) Cash from Operations (2016 - 2026)

Biogen has reported Cash from Operations over the past 18 years, most recently at 645500000.0 for Q1 2026.

For Q1 2026, Cash from Operations rose 148.94% year-over-year to 645500000.0; the TTM value through Mar 2026 reached 2590800000.0, changed 0.36%, while the annual FY2025 figure was 2204600000.0, 23.33% down from the prior year.
Cash from Operations for Q1 2026 was 645500000.0 at Biogen, up from 511900000.0 in the prior quarter.
Over five years, Cash from Operations peaked at 1272500000.0 in Q3 2025 and troughed at 175000000.0 in Q4 2022.
A 5-year average of 509241176.47 and a median of 553200000.0 in 2024 define the central range for Cash from Operations.
Biggest five-year swings in Cash from Operations: plummeted 120.88% in 2022 and later soared 5987.2% in 2024.
Year by year, Cash from Operations stood at 175000000.0 in 2022, then skyrocketed by 107.14% to 12500000.0 in 2023, then soared by 5987.2% to 760900000.0 in 2024, then tumbled by 32.72% to 511900000.0 in 2025, then grew by 26.1% to 645500000.0 in 2026.
Business Quant data shows Cash from Operations for BIIB at 645500000.0 in Q1 2026, 511900000.0 in Q4 2025, and 1272500000.0 in Q3 2025.